Panabyte Technologies Ltd.
Panabyte Technologs
₹ 0.00
0.00 (0.00)%
NSE
BSE
Trading
Small-cap - With a market cap of ₹19.92 Cr.
| EX-Date | Purpose |
|---|---|
| 28 06 2021 | Audited Results |
| 13 08 2021 | Quarterly Results |
| 11 11 2021 | Quarterly Results |
| 31 01 2022 | Quarterly Results |
| 30 05 2022 | Audited Results |
| 08 08 2022 | Quarterly Results |
| 08 11 2022 | Quarterly Results |
| 13 02 2023 | Quarterly Results |
| 30 05 2023 | Audited Results |
| 12 08 2023 | Quarterly Results |
| 03 11 2023 | Quarterly Results |
| 30 01 2024 | Quarterly Results |
| 09 02 2024 | Preferential Issue of shares & Right Issue of Equity Shares with Warrants |
| 12 11 2024 | Quarterly Results |
| 17 01 2025 | Issue Of Warrants(Cancelled) (Cancelled) |
| 17 01 2025 | Issue Of Warrants |
| 21 01 2025 | Issue Of Warrants |
| 23 01 2025 | Issue Of Warrants (Revised) |
| 05 02 2025 | Inter alia, to re-consider, evaluate and if deem fit to approve the proposal for raising of funds by way of issuance of securities / warrants convertible into equity shares of the Company through permissible modes including preferential allotment, in accordance with the provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and the Companies Act, 2013, as amended, subject to requisite approvals including shareholders and statutory approvals since the earlier proposal approved by the Board of Directors in its meeting held on 23rd January 2025 was not materialised. |
| 12 02 2025 | Quarterly Results |
| 22 05 2025 | Audited Results |
| 13 08 2025 | Quarterly Results |
| 01 10 2025 | Preferential Issue of shares & Inter alia, to consider and evaluate and if deem fit to approve the proposal for raising of funds by way of issuance of securities / warrants convertible into equity shares of the Company through permissible modes including preferential allotment pursuant to regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, and the Companies Act, 2013, as amended, subject to requisite approvals including shareholders and statutory approvals. |
| 13 11 2025 | Quarterly Results |
| 11 02 2026 | Quarterly Results |
